BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21614508)

  • 1. Diagnosis and treatment of prostate cancer in renal-transplant recipients.
    Binsaleh S
    Int Urol Nephrol; 2012 Feb; 44(1):149-55. PubMed ID: 21614508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen.
    Morton JJ; Howe SF; Lowell JA; Stratta RJ; Taylor RJ
    Br J Urol; 1995 Apr; 75(4):498-501. PubMed ID: 7540481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate.
    Zagars GK; Pollack A; Smith LG
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):809-19. PubMed ID: 10386637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy of prostate cancer in renal transplant recipients: single-center experience.
    Gojdic M; Zilinska Z; Krajcovicova I; Lukacko P; Grezdo J; Obsitnik B; Breza J; Trebaticky B
    Neoplasma; 2019 Jan; 66(1):155-159. PubMed ID: 30509098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades.
    Waeckel T; Ait Said K; Altieri M; Belin A; Doerfler A; Tillou X
    Int Urol Nephrol; 2021 Feb; 53(2):241-248. PubMed ID: 32926314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant radiotherapy for a prostate cancer after renal transplantation and review of the literature.
    Detti B; Scoccianti S; Franceschini D; Villari D; Greto D; Cipressi S; Sardaro A; Zanassi M; Cai T; Biti G
    Jpn J Clin Oncol; 2011 Nov; 41(11):1282-6. PubMed ID: 21940734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum prostate-specific antigen in hemodialysis patients.
    Sumura M; Yokogi H; Beppu M; Honda H
    Int J Urol; 2003 May; 10(5):247-50. PubMed ID: 12694463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
    Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
    Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
    Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
    J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate.
    Freeman JA; Lieskovsky G; Grossfeld G; Esrig D; Stein JP; Cook DW; Petrovich Z; Chen SC; Groshen S; Skinner DG
    Urology; 1994 Nov; 44(5):719-25. PubMed ID: 7526528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
    Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
    Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Blank K; Broderick GA; Tomaszewski JE; Renshaw AA; Kaplan I; Beard CJ; Wein A
    JAMA; 1998 Sep; 280(11):969-74. PubMed ID: 9749478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation.
    Sands ME; Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):13-9. PubMed ID: 7527796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical Prostatectomy for Localized Prostate Cancer in Renal Transplant Recipients: 13 Cases Studied at a Single Center.
    Iwamoto K; Iizuka J; Hashimoto Y; Kondo T; Takagi T; Hata K; Unagami K; Okumi M; Ishida H; Tanabe K
    Transplant Proc; 2018 Oct; 50(8):2539-2544. PubMed ID: 30316394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone Suppression with Luteinizing Hormone-Releasing Hormone (LHRH) Agonists in Patients Receiving Radiotherapy for Prostate Cancer.
    Wilke D; Patil N; Hollenhorst H; Bowes D; Rutledge R; Ago C
    Pharmacotherapy; 2018 Mar; 38(3):327-333. PubMed ID: 29337395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
    Stamey TA
    Urologe A; 1990 Mar; 29(2):52-64. PubMed ID: 1691883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.